CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L306. A total of 21 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $3,000 | 0.0% | 8,189 | +23.2% | 0.00% | – |
| Q4 2015 | $3,000 | -95.8% | 6,649 | -91.6% | 0.00% | – |
| Q1 2015 | $71,000 | -13.4% | 79,367 | -32.6% | 0.00% | – |
| Q4 2014 | $82,000 | -59.0% | 117,778 | +78.8% | 0.00% | – |
| Q3 2014 | $200,000 | -7.8% | 65,854 | -6.8% | 0.00% | – |
| Q2 2014 | $217,000 | -14.2% | 70,631 | +2.9% | 0.00% | – |
| Q1 2014 | $253,000 | +4.5% | 68,615 | +13.8% | 0.00% | – |
| Q4 2013 | $242,000 | -1.6% | 60,299 | +4.4% | 0.00% | – |
| Q3 2013 | $246,000 | +106.7% | 57,779 | +43.4% | 0.00% | – |
| Q2 2013 | $119,000 | – | 40,296 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 1,077,465 | $3,179,000 | 0.56% |
| DAFNA Capital Management LLC | 44,300 | $131,000 | 0.19% |
| Perceptive Advisors | 350,000 | $1,033,000 | 0.10% |
| Catalyst Capital Advisors LLC | 43,000 | $127,000 | 0.10% |
| TANG CAPITAL MANAGEMENT LLC | 73,895 | $218,000 | 0.09% |
| Invesco Private Capital | 116,316 | $343,000 | 0.04% |
| Allianz Asset Management GmbH | 559,207 | $1,650,000 | 0.00% |
| A.R.T. Advisors, LLC | 19,507 | $57,000 | 0.00% |
| BARCLAYS PLC | 230,000 | $679,000 | 0.00% |
| KNIGHT CAPITAL GROUP LLC | 26,263 | $77,000 | 0.00% |